E160230409Ann.indd

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Town Health International Medical Group Limited

康健國際醫療集團有限公司

(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)

(Stock Code: 3886) NOTICE OF ANNUAL GENERAL MEETING NOTICE IS HEREBY GIVEN that the annual general meeting of Town Health International Medical Group Limited ("Company") will be held at 10 a.m. on Friday, 17 June 2016 at 1st Floor, Town Health Technology Centre, 10-12 Yuen Shun Circuit, Siu Lek Yuen, Shatin, New Territories, Hong Kong for the following purposes:
  1. To receive and consider the audited consolidated financial statements of the Company, the report of the directors and the independent auditor's report for the year ended 31 December 2015.

  2. To declare a final dividend of HK0.98 cent per ordinary share for the year ended 31 December 2015.

  3. To re-elect the following retiring directors of the Company:

    1. Miss Choi Ka Yee, Crystal as an executive director of the Company;

    2. Dr. Cho Kwai Chee as an executive director of the Company;

    3. Dr. Hui Ka Wah, Ronnie, JP as an executive director of the Company;

    4. Dr. Choi Chee Ming, GBS, JP as a non-executive director of the Company;

    5. Mr. Ho Kwok Wah, George, MH as an independent non-executive director of the Company;

    6. Mr. Tsai Ming-hsing as a non-executive director of the Company; and

    7. Mr. Wang John Hong-chiun as an independent non-executive director of the Company.

    8. To authorise the board of directors of the Company to fix the directors' remuneration.

    9. To re-appoint Deloitte Touche Tohmatsu as the auditors of the Company and authorise the board of directors of the Company to fix their remuneration.

      As special business, to consider and, if thought fit, pass the following resolutions as ordinary resolutions:

      ORDINARY RESOLUTIONS
    10. "THAT:

      1. subject to paragraph (C) of this resolution, the exercise by the directors of the Company during the Relevant Period (as defined below) of all the powers of the Company to allot, issue or otherwise deal with new ordinary shares in the share capital of the Company ("Shares") or securities convertible into Shares, or options, warrants or similar rights to subscribe for any Shares, and to make or grant offers, agreements, options and warrants which would or might require the exercise of such powers be and is hereby generally and unconditionally approved;

      2. the approval in paragraph (A) of this resolution shall authorise the directors of the Company during the Relevant Period to make or grant offers, agreements, options and warrants which would or might require the exercise of such powers after the end of the Relevant Period;

      3. the number of Shares allotted, issued or dealt with or agreed conditionally or unconditionally to be allotted, issued or dealt with (whether pursuant to an option or otherwise) by the directors of the Company pursuant to the approval in paragraph (A) of this resolution, otherwise than pursuant to Shares issued as a result of a Rights Issue (as defined below), the exercise of the subscription or conversion rights attaching to any warrants issued by the Company or the exercise of options granted under any share option scheme of the Company or any scrip dividend providing for the allotment and issue of Shares in lieu of the whole or part of a dividend on Shares, shall not exceed the aggregate of:

        (aa) 20% of the number of issued Shares as at the date of the passing of this resolution; and

        (bb) (if the directors of the Company are so authorised by a separate ordinary resolution of the shareholders of the Company) the number of Shares purchased by the Company subsequent to the passing of this resolution (up to a maximum equivalent to 10% of the number of issued Shares as at the date of the passing of this resolution),

        and the authority pursuant to paragraph (A) of this resolution shall be limited accordingly;

      4. if, after the passing of this resolution, the Company conducts a share consolidation or subdivision, the number of Shares subject to the limit set out in paragraph (C) above shall be adjusted to the effect that the number of Shares subject to the limit set out in paragraph (C) above as a percentage of the total number of issued Shares at the date immediately before and after such consolidation or subdivision shall be the same; and

      5. for the purposes of this resolution:

        "Relevant Period" means the period from the date of passing of this resolution until whichever is the earliest of:

        1. the conclusion of the next annual general meeting of the Company;

        2. the expiration of the period within which the next annual general meeting of the Company is required by the bye-laws of the Company or any applicable law of Bermuda to be held; and

        3. the revocation or variation of the authority given under this resolution by an ordinary resolution of the shareholders of the Company in general meeting; and

        4. "Rights Issue" means the allotment, issue or grant of Shares pursuant to an offer of Shares open for a period fixed by the directors of the Company to the holders of Shares whose names appear on the register of members of the Company on a fixed record date in proportion to their then holdings of such Shares (subject to such exclusions or other arrangements as the directors of the Company may deem necessary or expedient in relation to fractional entitlements or having regard to any restrictions or obligations under the laws of, or the requirements of any recognised regulatory body or any stock exchange in, any territory applicable to the Company)."

        5. "THAT:

          1. subject to paragraph (B) of this resolution, the exercise by the directors of the Company during the Relevant Period (as defined below) of all the powers of the Company to purchase or repurchase ordinary shares in the share capital of the Company ("Shares") on, subject to and in accordance with all applicable laws and rules on The Stock Exchange of Hong Kong Limited or on any other stock exchange on which the Shares may be listed and recognised for this purpose by the Securities and Futures Commission of Hong Kong and The Stock Exchange of Hong Kong Limited, be and is hereby generally and unconditionally approved;

          2. the number of Shares which may be purchased or repurchased by the Company or agreed to be purchased or repurchased by the Company pursuant to the approval in paragraph (A) of this resolution during the Relevant Period shall not exceed 10% of the number of issued Shares as at the date of passing of this resolution, and the said approval shall be limited accordingly;

        Town Health International Medical Group Ltd. published this content on 30 April 2016 and is solely responsible for the information contained herein.
        Distributed by Public, unedited and unaltered, on 05 May 2016 10:09:06 UTC.

        Original documenthttp://www.townhealth.com/en/doc/LTN201604282124.pdf

        Public permalinkhttp://www.publicnow.com/view/2C231DE16A79E70CAB6B2DDE113C3B6F2ADFEB12